The Ellegaard Göttingen Minipigs Research Foundation has the main objective of maintaining and expanding the activities of Ellegaard Göttingen Minipigs A/S by providing funding for scientific research of the highest quality.
In 2018, the Ellegaard Göttingen Minipigs Research Foundation grants in total up to €50,000 to support scientific research that aims to characterize the Göttingen Minipig or promote the development of Göttingen Minipig disease models. In addition, projects that intend to improve animal welfare and/or optimize handling or research techniques as well as educational and communication activities related to the use of Minipigs in scientific research may receive funding.
The Ellegaard Göttingen Minipigs Research Foundation’s general criteria for granting research funds are that the scientific content of the application, the qualifications of the applicant and the academic environment of the host institution are at a high international level. The project should generate significant background data and/or ensure knowledge dissemination and promote the use of the Göttingen Minipig in scientific research.
The Foundation has set up a scientific committee to ensure uniform assessment of all project applications. Ellegaard Göttingen Minipigs management team will based on recommendations from the scientific committee allocate grants in accordance with statutory requirements.
We are very pleased to announce that the Scientific Board of Ellegaard Göttingen Minipigs Research Foundation has granted € 20,000 to the project “A transgenic CRISPR/Cas9 Göttingen Minipig to generate pre-clinical cancer models” led by Dr. Martin Kristian Thomsen, Associate Professor, Department of Clinical Medicine at Aarhus University, Denmark, who is leading the research team behind the project.
The Grant was announced on 23 May 2019 by CEO Lars Friis Mikkelsen (photo) during the 13th Minipig Research Forum in Vienna, Austria.
A second grant to another research project is expected to be allocated in December 2019. Read about the criteria for funding below and fill in the project application form and submit it by e-mail to Henrik Duelund Pedersen, CSO, Ellegaard Göttingen Minipigs no later than 15 October 2019.
We are very pleased to announce that the Scientific Board of Ellegaard Göttingen Minipigs Research Foundation has granted € 35,000 to the project “Speedgene targeted knock out of the PCSK-9 gene in Göttingen Minipigs” and the research teams behind the project, led by Dr. Jaya Krishnan and Dr. Jonathan Ward, Genome Biologics, together with Dr. Roy Forster, Citoxlab.
The grant was announced last week by CEO Lars Friis Mikkelsen during the 12th Minipig Research Forum in Barcelona. Director of Toxicology of Citoxlab France, Pramila Singh, was honoured to receive the diploma from Lars Friis Mikkelsen on behalf of the winning project team.
We are very pleased to announce that the Scientific Board of Ellegaard Göttingen Minipigs Research Foundation has granted a total of € 100,000.00 to Prof. Dr. Steven Van Cruchten and his research team from the University of Antwerp to support the project: “Construction and activity of recombinant cytochrome P450 enzymes as an in vitro system for reaction‐phenotyping of drug candidates in the Göttingen Minipig”.